Use of Sentinel Cells for the Development of Molecular Tests to Control the Quality of Cryopreservation

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01904825

Enrollment

Registered

2013-07-22

Start date

2006-09-30

Completion date

2009-08-31

Last updated

2013-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aneurysm of the Abdominal Aorta

Brief summary

The aim is to set up tools that will serve as quality tracers for cryopreservation procedures. To meet this objective, we have chosen to develop reference samples (sentinel cells) that, in the medium term, can be used as controls to guarantee the quality of preservation for biological samples. The biological tools and an optimised follow-up strategy will make it possible to validate preservation procedures at the CRB in order to guarantee the perfect stability of samples and the validity of clinical studies.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Age \> or = 18 years * All patients presenting an abdominal aorta diameter of at least 5 cm at the time of discovery and who have surgery

Exclusion criteria

* Patients who do not have aneurysm of the abdominal aorta * Refusal to sign the consent form for participation * Patients who do not wish to have their operation in Dijon or Strasbourg CHU

Design outcomes

Primary

Measure	Time frame
Quality sentinel cells	participants will be followed for the duration of hospital stay, an expected average of 6 months

Outcome results